Skip to content

Atrial Fibrillation Health Center

Font Size

Study: New Anticlotting Drug Beats Warfarin

Eliquis More Effective at Preventing Strokes in Patients With Atrial Fibrillation

Pros and Cons of New Drugs continued...

Brindis and Bohm agree that the newer agents will probably prove most useful for patients being prescribed anticlotting drugs for the first time and those for whom warfarin dosing proves problematic.

"If warfarin has been working with no problems, and the patient isn't all upset about the blood work, there is no reason to switch," Brindis explains.

The Eliquis study, dubbed Aristotle, was funded by Bristol-Myers Squibb and Pfizer. Bristol-Myers said an application for approving Eliquis for AF will be filed with the FDA later this year.

1|2|3

Today on WebMD

pacemaker next to xray
Ablation, cardioversion, pacemaker, and more.
human brain
What you need to know.
 
woman doing yoga
Tips for easing stress.
fish and vegetables
Diet guidelines to follow.
 
Omega 3 Overview Slideshow
Slideshow
At Risk for Heart Disease
Video
 
Recognizing Womens Heart Symptoms
FEATURE
Simple Steps to Lower Cholesterol
Slideshow
 

Resolved To Quit Smoking
SLIDESHOW
Lowering Blood Pressure Slideshow
SLIDESHOW
 
Heart Disease And Ed
SLIDESHOW
Heart Attack Spit Test
Video
 

WebMD Special Sections